• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Allergen to buy shire Neuroscience division

anonymous

Guest
shire is spinning off neuroscience division in January. The rep in my territory is a puts anyway. We are going to swallow them up and feed there sales force to the crows lol
 








shire is spinning off neuroscience division in January. The rep in my territory is a puts anyway. We are going to swallow them up and feed there sales force to the crows lol
Apparently your arrogant, ignorant ass has not been in this industry long enough to understand how many people suffer when companies "swallow up" other companies! Wait until it is your family's welfare on the line, wait until someone threatens your livelihood before you spout off your childish, insensitive mouth. I would like to see you standing in front of me, looking me in my eyes, and have the guts to say you are going to feed anyone to the crows...maybe we can have a discussion about my young children that could be involved as their parent goes through the torment of a possible lay-off...or better yet, maybe we could discuss your family!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! We are ALL THE SAME! You are no better than I. However, one day, you will be taught a very valuable lesson about life, and maybe then you will learn to be decent!